|
Market Closed -
NYSE
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.480 USD | +3.33% |
|
+5.53% | +37.78% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 200M 172M 161M 147M 277M 19.06B 279M 1.91B 738M 9.61B 750M 734M 31.85B | P/E 2026 * |
13.1x | P/E 2027 * | 45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 200M 172M 161M 147M 277M 19.06B 279M 1.91B 738M 9.61B 750M 734M 31.85B | EV / Sales 2026 * |
2.5x | EV / Sales 2027 * | 2.93x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Protalix BioTherapeutics, Inc.
| 1 day | +3.33% | ||
| 1 week | +5.53% | ||
| Current month | +4.64% | ||
| 1 month | +4.64% | ||
| 3 months | +15.89% | ||
| 6 months | -17.61% | ||
| Current year | +37.78% |
| 1 week | 2.34 |  | 2.48 |
| 1 month | 2.17 | | 2.7 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.52 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 29/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 23/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 30/06/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 31/10/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 29/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Executive Officer | 56,000 | 0.0696% | ||
| 18/11/25 | Sell | Director | 168 | 0.0002% | ||
| 03/09/25 | Free | Chief Operating Officer | 75,000 | 0.0941% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.33% | +5.53% | +53.09% | +28.50% | 200M | |
| -3.59% | -7.10% | +61.60% | +114.83% | 1,060B | |
| -1.15% | -1.25% | +52.98% | +62.41% | 651B | |
| -1.09% | -1.15% | +26.18% | +79.22% | 465B | |
| -0.90% | -1.64% | +39.26% | +41.12% | 365B | |
| -1.20% | -0.36% | +23.44% | +39.16% | 300B | |
| -0.55% | +1.15% | +2.66% | +12.81% | 258B | |
| -0.43% | -0.46% | +52.06% | +71.75% | 238B | |
| -2.98% | +0.68% | -16.41% | -53.88% | 210B | |
| -0.46% | +0.33% | +29.05% | +92.67% | 184B | |
| Average | -0.64% | -0.34% | +32.39% | +48.86% | 373.06B | |
| Weighted average by Cap. | -0.75% | -2.15% | +39.75% | +67.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.8M 68.49M 64.28M 58.71M 111M 7.61B 111M 761M 295M 3.84B 300M 293M 12.72B | 68.19M 58.53M 54.94M 50.18M 94.69M 6.5B 95.15M 650M 252M 3.28B 256M 250M 10.87B |
| Net income | 15.38M 13.2M 12.39M 11.31M 21.35M 1.47B 21.45M 147M 56.81M 740M 57.73M 56.48M 2.45B | 4.46M 3.83M 3.6M 3.28M 6.2M 426M 6.23M 42.55M 16.49M 215M 16.76M 16.39M 711M |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26/08/26 | US$2.480 | +3.33% |
| 25/08/26 | US$2.400 | -0.41% |
| 24/08/26 | US$2.410 | +1.26% |
| 21/08/26 | US$2.380 | 0.00% |
| 20/08/26 | US$2.380 | +1.28% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
